Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

California Institute for Quantitative Biosciences

California Institute for Quantitative Biosciences

California Institute for Quantitative Biosciences is an acceleration firm which specializes in seed, incubation and acceleration of companies. It is California's hub for innovation and entrepreneurship in the life sciences. The institute supports University of California's researchers and empowers Bay Area entrepreneurs to launch startup companies and partner with industry. QB3's mission is to grow the California bioeconomy. It was founded in 2000 and is based in San Francisco, California.

Investor Status
Actively Seeking New Investments
Year Founded
Primary Investor Type
Other Investor Types
Venture Capital
VC-Backed Company
Primary Office
  • Suite 214, Byers Hall
  • UCSF Mission Bay, 1700 4th Street
  • San Francisco, CA 94158
  • United States

+1 (415) 000-0000

California Institute for Quantitative Biosciences Investments (224)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Karuna 30-Jan-2019 Seed Round 00.00 Therapeutic Devices Generating Revenue
000000 00000000000 06-Jul-2018 000000000000 Biotechnology Clinical Trials - Phase 2
0000000 0000000 27-Jun-2018 000000000000 Other Devices and Supplies Generating Revenue
000000000 000000 22-Jun-2018 000000000000 Diagnostic Equipment Startup
0000000 00000 11-Jun-2018 000000000000 Food Products Startup
000000000 00000000 01-May-2018 000000000000 Biotechnology Startup
000000000 20-Apr-2018 00000 00000 00.000 Medical Supplies Generating Revenue
0000000 0000000000 18-Jan-2018 00000 00000 00000 Biotechnology Startup
Actym Therapeutics 03-Jan-2018 Accelerator/Incubator Biotechnology Startup
Scribe Biosciences 06-Nov-2017 Accelerator/Incubator Biotechnology Startup
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore California Institute for Quantitative Biosciences’s full profile, request a free trial.

California Institute for Quantitative Biosciences Exits (26)

Company Name Exit Date Exit Type Exit Size Status Buyers
Atreca 20-Jun-2019 IPO 00000 Completed
0000000 07-Feb-2019 000 00000 Completed
000000000 00000000 14-Sep-2018 000 00000 Completed
  • 000000000000000
00000 000000 01-Sep-2018 000 00 00000000 Completed
000000000 00000000 01-Sep-2018 000 00 00000000 Completed
0000000 21-Jun-2018 0000000000 Completed
  • 000000000 00000000
00000 000000000000 20-Jun-2018 000 00000 Completed
00000000 09-May-2018 000000000000000000 Completed
  • 000 (0000000000000
Alloonc 01-Mar-2018 Out of Business Completed
Gemmus Pharma 14-Dec-2017 Out of Business Completed
To view this investor’s complete exits history, request access »

California Institute for Quantitative Biosciences Team (11)

Name Title Deals Funds Boards Office Contact
Jan Ambrosini Communications Director Berkeley, CA
Christine Winoto Deputy Director San Francisco, CA
Nevan Krogan Ph.D Director San Francisco, CA
Susan Marqusee Ph.D Director Berkeley, CA
Kaspar Mossman Ph.D Director of Communications and Marketing 0 San Francisco, CA

2 Former Team Members

You’re viewing 5 of 11 team members. Get the full list »

California Institute for Quantitative Biosciences Co-Investors (86)

Name With Exits Lead Partner
Mission Bay Capital 6 0
IndieBio 0
MedTech Innovator 0
HBM Healthcare Investments 0 0
Valor Equity Partners 0 0
To view this investor’s complete co-investor history, request access »